Results 41 to 50 of about 2,573 (204)

Challenging scenarios in HoLEP

Urology Video Journal
Introduction and objectives: Holmium laser enucleation of the prostate (HoLEP) is a gold standard treatment for benign prostatic hyperplasia (BPH). It provides robust symptom relief and low re-operative rates while being size independent. There are several challenging scenarios that can be encountered by surgeons that require a systematic approach to ...
Alejandro Bautista-Pérez-Gavilán, Cyrus Chehroudi, Elsayed Desouky, Jamal Alamiri, Smita De   +4 more
openaire   +2 more sources

Cellular Angiofibroma of the Prostate

IJU Case Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Introduction Cellular angiofibroma is a rare, benign mesenchymal tumor that affects middle‐aged adults. It most frequently arises in the vulvovaginal or inguinoscrotal region. It is characterized by a slow clinical progression with no known potential for recurrence or metastasis.
Fien Janssens, Celia Perdaens, Isabelle Vanden Bempt, Raf Sciot, Hans Vandendriessche   +4 more
wiley   +1 more source

Is It Necessary to Remove the Maximum Prostate Tissue in All Patients? the Percentage of Resected Prostate Tissue and the Influence on Surgery Outcomes: A One‐Year Follow Up Study

Neurourology and Urodynamics, Volume 45, Issue 1, Page 115-119, January 2026.
ABSTRACT Introduction To investigate whether the volume of the prostate tissue resected on TURP influences on short and medium term follow up. Methods It was developed a prospective study between May 2020 and August 2022, embracing patients with severe LUTS due to BPO, including clinical and urodynamic parameters meeting obstruction criteria (BOOI > 40)
Bruno Rodrigues Lebani, André Barcelos da Silva, Luciano Teixeira Silva, Marcia Eli Girotti, Eduardo Remaile Pinto, Milton Skaff, Fernando Gonçalves Almeida   +6 more
wiley   +1 more source

Clinical outcome and safety of holmium laser prostate enucleation after transrectal prostate biopsies for benign prostatic hyperplasia [PDF]

Investigative and Clinical Urology
Purpose: This study aimed to assess the clinical outcome and safety of holmium laser enucleation of the prostate (HoLEP) following transrectal ultrasound-guided prostate biopsy (TR biopsy) in the treatment of benign prostate hyperplasia.
See Min Choi , Chang Seok Kang, Dae Hyun Kim, Jae Hwi Choi, Chunwoo Lee, Seong Uk Jeh, Sung Chul Kam, Jeong Seok Hwa, Jae Seog Hyun   +8 more
doaj   +1 more source

Holmium laser enucleation of the prostate: a 3-year single-center experience of 173 cases

African Journal of Urology, 2022
Background Holmium laser enucleation of the prostate (Holep) is a safe, effective, and prostate size-independent procedure for benign prostatic hyperplasia treatment (BPH). Holep has demonstrated comparable long-term outcomes with historical BPH mainstay
Roland B. Banga-Mouss, Raphaël Briffaux, Joseph Junior Damba, Thomas Charles, Alexis Puichaud, Humphrey Robin, Edwin Angermann, Christophe Pires, Anani W. Severin Odzebe, Charlie Ouaki   +9 more
doaj   +1 more source

Current techniques for laser prostatectomy-PVP and HoLEP [PDF]

Archivos Españoles de Urología (Ed. impresa), 2008
The objective of this review is to provide an evidence-based update on laser surgery for BPH with a focus on comparing Greenlight Photoselective Vaporisation of the Prostate (PVP) to Holmium Laser Enucleation of the Prostate (HoLEP).We reviewed all HoLEP and PVP papers identified by a Pubmed search using the keywords: laser, prostate, BPH, holmium ...
Aho, Tevita F., Gilling, Peter J.
openaire   +4 more sources

Rezūm Therapy in Very Elderly Men With BPH: Two‐Year Outcomes From a Multicenter Cohort

LUTS: Lower Urinary Tract Symptoms, Volume 18, Issue 1, January 2026.
ABSTRACT Objectives Rezūm water vapor thermal therapy is a minimally invasive surgical option with demonstrated efficacy and safety. However, real‐world evidence on 2‐year outcomes in the population aged above 80 years remains limited. Methods A prospective registry was created as part of the International Rezūm Registry database at two high‐volume ...
Mario Henrique Bitar Siqueira, Sagi Shprits, Naeem Bhojani, Bilal Chughtai, Kevin C. Zorn, Luca Cindolo, Giovanni Ferrari, Katherine Lajkosz, Dean Elterman   +8 more
wiley   +1 more source

Sexual Outcomes and Symptom Relief Following HoLEP Versus BipoLEP: A Prospective Cohort Study

Andrologia, Volume 2026, Issue 1, 2026.
Objective To prospectively compare the effects of Holmium Laser Enucleation of the Prostate (HoLEP) and Bipolar Transurethral Enucleation of the Prostate (BipoLEP) on erectile function and lower urinary tract symptom (LUTS) outcomes in men undergoing surgery for benign prostatic hyperplasia (BPH).
Abdulmecit Yavuz, Onder Cinar, Harleen Khatra   +2 more
wiley   +1 more source

One‐year outcomes after prostate artery embolization versus laser enucleation: A network meta‐analysis

BJUI Compass
Background Although holmium laser enucleation (HoLEP) is considered a size‐independent procedure for treatment of an enlarged prostate, prostate artery embolization (PAE) is emerging as an alternative modality to treat moderate and large benign prostatic
Ansh Bhatia, Joao Gabriel Porto, Aneesha Maini, Deepak Langade, Thomas R. W. Herrmann, Hemendra Navinchandra Shah, Shivank Bhatia   +6 more
doaj   +1 more source

Thulium fibre laser endoscopic enucleation of the prostate (THUFLEP) learning curve assessment: A retrospective analysis of the experience of a single surgeon

BJUI Compass, Volume 6, Issue 12, December 2025.
Abstract Objectives To assess the learning curve of thulium fibre laser enucleation of the prostate (THUFLEP). Patients and methods We conducted a retrospective study including the first 111 patients treated with THUFLEP by a single surgeon. The operator had no prior experience in prostate enucleation and performed the first two procedures under the ...
Sulaiman Goudaimy, Louis Lenfant, Christophe Vaessen, Jérôme Parra, Emmanuel Chartier‐Kastler, Aurélien Beaugerie, Pierre Mozer, Quentin Dubourg, Thomas Seisen, Morgan Roupret, Ugo Pinar   +10 more
wiley   +1 more source